Bjorn Ekstrom

Bjorn Ekstrom has extensive experience in the biotechnology and medical technology sectors, serving on the board of directors for multiple companies including Cray Innovation AB, Ginolis Ltd, and Olink AB, in addition to holding the position of Chairman and CEO at Becan AB. Bjorn's tenure at Cray Innovation AB, focused on the implications of chromosome Y loss in medical research, and Ginolis Ltd, specializing in diagnostic automation solutions, highlights significant contributions to the industry. With prior roles at Cobolt AB, Sigolis AB, Modpro AB, Qlinea AB, and Halo Genomics AB, along with a solid educational background in Chemistry from Lund University and current Honorary Doctor studies at Uppsala University, Bjorn Ekstrom exemplifies a strong leadership presence and expertise in life sciences.